Health1 month ago
Amgen Downgraded to Hold Amid Valuation Concerns and Mixed Q4 Results
Amgen Inc. has been downgraded to a “hold” rating, reflecting a deteriorating risk/reward profile following recent stock performance and valuation expansion. Analysts have noted that while...
